交易 Aurinia Pharmaceuticals Inc. - AUPH 差价合约

交易条件

• 类型: 差价合约
• 点差: 0.1
• 长仓隔夜仓息调整: -0.02151%
• 短仓隔夜仓息调整: -0.00071%
• 隔夜调整仓息时间: 21:00 (UTC)
• 货币: USD
• 最低成交量: 1
• 保证金: 5.00%
• 证券交易所: United States of America
• 交易佣金: 0%
• 保证止损溢价: 1%

主要统计数据

• 前收盘价: 16.09
• 开仓: 16.23
• 1 年变化: 105.18%
• 日区间: 16.16 - 16.43

交易 Aurinia Pharmaceuticals Inc. - AUPH 差价合约

Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States. The company also offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. Aurinia Pharmaceuticals Inc. is headquartered in Victoria, Canada.